Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. - Wikidata - awgldk - TriplyDB

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

http://www.wikidata.org/entity/Q34513594

about

Emergency Department Management of Suspected Calf-Vein Deep Venous Thrombosis: A Diagnostic Algorithm Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016 Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences Treatment of patients with chronic thrombo embolic pulmonary hypertension: focus on riociguat Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy Cancer-associated thrombosis in Asia Pulmonary embolism: new treatments for an old problem Management of venous thromboembolism: an update Pulmonary embolism: the diagnosis, risk-stratification, treatment and disposition of emergency department patients Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies Venous Thromboembolism - Current Diagnostic and Treatment Modalities Should oral anticoagulant therapy be continued during dental extraction? A meta-analysis Pulmonary Embolism: The Astute Interventional Radiology Clinician.The postthrombotic syndrome: current evidence and future challenges.Can we prevent venous thrombosis with statins: an epidemiologic review into mechanism and clinical utility.Achieving Multidisciplinary Collaboration for the Creation of a Pulmonary Embolism Response Team: Creating a "Team of Rivals".Utilization and prescribing patterns of direct oral anticoagulants.A critical balance: managing coagulation in patients with glioma.Controversies in the management of cancer-associated thrombosis.Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopenia.Population Pharmacokinetics, Pharmacodynamics, and Exploratory Exposure-Response Analyses of Apixaban in Subjects Treated for Venous Thromboembolism.Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complications Observation management of pulmonary embolism and agreement with claims-based and clinical risk stratification criteria in United States patients: a retrospective analysis.Venous thromboembolism management in Northeast Melbourne - How does it compare to international guidelines and data?External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches.Vascular disease in the older adult.Relationship between polycythemia and in-hospital mortality in chronic obstructive pulmonary disease patients with low-risk pulmonary embolism Advanced imaging in acute and chronic deep vein thrombosis Pathogenesis of Thromboembolism and Endovascular Management.Management of Venous Thromboembolism in Patients with Hereditary Antithrombin Deficiency and Pregnancy: Case Report and Review of the Literature.Venous Thromboembolism in Children with Cancer and Blood Disorders.Warfarin associated venous limb gangrene in cancer-related DVT (case report)Massive hemoptysis in a patient with pulmonary embolism, a real therapeutic conundrum.Risk factors for major bleeding in the SEATTLE II trial.Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide.IVC filters-Trends in placement and indications, a study of 2 populations

P2860

Q26739510-7F6A3BC2-0929-4852-B54E-1CAB1393320F Q26741697-C9D05AA3-E1A5-4320-AAA2-92FA90E34BDB Q26743727-62A2AC4E-4757-400E-9CA5-D5B3A12F05C4 Q26746062-608C2C18-32DF-4B93-A749-EB9B79768546 Q26746202-D6199992-914D-4FBA-8731-514D29A7A792 Q26766303-EAA7F5C2-E33A-4E4D-A578-DDCFF1C3E8CF Q28070193-10963C33-7A57-4B88-BFAE-3B0B4F0622B3 Q28070346-EB82BC83-E5E2-46A1-AC91-AAD7020724B9 Q28071443-1D4D8559-9C51-4A2F-A128-B49AD547E84C Q28074248-78E17DB6-BA2B-4B99-8BA7-A508E33C16DE Q28078747-167B1031-795D-4F98-916D-FD91D8D0DEC0 Q28078966-19F18A31-E442-48E4-A65F-AC7767AC6DBD Q28278099-72361302-FF37-49BB-9C1C-A89B4B6DAF12 Q30235407-9CC9BBC6-5568-443C-9FE6-8172FE7686E6 Q30241064-367C7252-B891-49AD-9517-90C09ABD76CA Q30243926-4054A38E-5199-4608-84CE-48707ECC696B Q30399523-247388AB-3D5C-4193-8EA5-7AD81863CA04 Q30842114-1969CB28-E53A-49EB-BA0C-C332D510D567 Q33431673-281062CD-B698-48C7-A181-D222BCB5D42E Q33436975-0A1FD805-B991-4B19-9FEC-EDF4EB8BF701 Q33442116-72766806-DA77-43E3-96A7-D146621FB60B Q33729811-5B8E18AE-F9F3-4487-84E9-9B6B822AF07E Q33794274-2A3164FC-90F5-46F0-8ADA-5C4CB235DA8B Q33851708-F91BF4CF-F19A-4F3B-88F6-0F4A495B3470 Q36003924-FBD5AD53-2552-49E6-8555-3AE9BFF72F50 Q36172141-2E243EDA-26C8-4089-A458-0DF23D1C8776 Q36279093-3D8B227A-A214-4678-AAD8-20A7EF7CF367 Q36411009-0EF0F4D8-21F9-4844-B53F-2333C1D747FB Q36682689-4668EED8-62AA-4410-8E12-800E5030A1FE Q37437828-1A82FD23-7EC2-403A-A5B5-1B59104CB830 Q37528325-BB7BAC40-2C95-4A3C-87DE-E152920F5254 Q37570813-DDC85F3F-FD7E-43F7-A9A3-42F05C826CA0 Q37592931-D94B7861-BFAB-491F-B9DB-AAB5DD963B2B Q37601960-0D1A1C83-86E7-4A35-8F9E-676D65C1325F Q37625771-6B72AF33-B772-4A23-BA2B-E2D3267F877E Q37672604-2014DE8A-3C8D-4559-867E-3C189AFCD118 Q37683335-455D89B5-623F-4044-95EA-54243D1C91D9 Q37695657-04A6126B-D4AA-4042-BB7A-D725457D0F2E Q37699699-D1AD1FB4-34A3-4DD2-A087-9F5B46A2CABE Q37727306-561DF6CD-E3CE-41A4-B04E-7B5CC8AF7841

P2860

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

http://www.wikidata.org/entity/Q34513594

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

@ast

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

@en

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

@nl

type

label

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

@ast

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

@en

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

@nl

prefLabel

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

@ast

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

@en

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

@nl

P1433

Q34513594-A14D0BBB-B0ED-4E67-AFBC-168B9FFA6582

P1476

Q34513594-C2E5E95F-88F8-4F27-A76B-22B050C4A721

P2093

Q34513594-3045706C-C05D-4863-BF35-04235002F752

Q34513594-30E0166C-1213-46B1-AF8D-4BA726901E68

Q34513594-4BCAEAD9-FB47-4202-886C-39E36375507E

Q34513594-52C09D91-D25F-4ADC-ACC8-A6F3791431F9

Q34513594-5CEB34A4-D28D-4302-A5A2-E72F918B978A

Q34513594-8E0DF86E-32FA-4E25-BE12-5BE21C01E9F4

Q34513594-8F4B8109-8B25-4EDF-8657-7E0A1E41D30D

Q34513594-AB9A742B-80CC-45D6-B4B5-FDA4F35E2C8C

Q34513594-AD6AFD87-55A2-4E82-81C2-8CFAD7B37F70

Q34513594-BEF3CCF2-8EB9-4665-925C-D2CE593B3EB8

P304

Q34513594-B6B09FE8-FAC2-45D4-932D-3DFAFF36E013

P31

Q34513594-7DBC9E74-4263-4B5D-8F83-B5ECC36873C0

P356

Q34513594-CE5AE8C6-1630-4017-942E-BB4D28DB1103

P407

Q34513594-5BDCF5CF-FA33-47C4-8B78-45B2166A9A85

P433

Q34513594-3EBF2BAB-D379-4A9B-B949-6C02B39DD73E

P478

Q34513594-E0B21631-30FB-41AB-8359-8DE33D2007EC

P50

Q34513594-0F87EE4C-B59D-4B90-940B-408D8FE86FC5

P577

Q34513594-6B913709-00ED-43F7-A054-41942F4CA305

P698

Q34513594-E93BCAFB-CEA1-4E21-B6D9-C67D92C208A7

P356

J.CHEST.2015.11.026

P1433

P1476

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

@en

P2093

Allen Blaivas

http://www.w3.org/2001/XMLSchema#string

Christopher S King

http://www.w3.org/2001/XMLSchema#string

Clive Kearon

http://www.w3.org/2001/XMLSchema#string

David Jimenez

http://www.w3.org/2001/XMLSchema#string

Elie A Akl

http://www.w3.org/2001/XMLSchema#string

Henri Bounameaux

http://www.w3.org/2001/XMLSchema#string

Janine R E Vintch

http://www.w3.org/2001/XMLSchema#string

Joseph Ornelas

http://www.w3.org/2001/XMLSchema#string

Lisa Moores

http://www.w3.org/2001/XMLSchema#string

Menno Huisman

http://www.w3.org/2001/XMLSchema#string

P304

315-352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CHEST.2015.11.026

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

149

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26867832

http://www.w3.org/2001/XMLSchema#string